BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38769516)

  • 1. Early myocardial injury in children on doxorubicin for cancer chemotherapy: a cross-sectional study in a tertiary referral centre in Kenya.
    Kariuki N; Kimani E; Jowi C; Wamalwa D; Suen JY; Fraser JF; Obonyo NG
    BMC Cardiovasc Disord; 2024 May; 24(1):260. PubMed ID: 38769516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
    Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
    Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cardiac dysfunction in children on treatment for cancer at Kenyatta National Hospital, Nairobi.
    Shiroya-Wandabwa M; Yuko-Jowi C; Nduati R; Githanga J; Wamalwa D
    East Afr Med J; 2009 Dec; 86(12 Suppl):S52-7. PubMed ID: 21591510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin.
    Kismet E; Varan A; Ayabakan C; Alehan D; Portakal O; Büyükpamukçu M
    Pediatr Blood Cancer; 2004 Mar; 42(3):220-4. PubMed ID: 14752858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
    Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
    Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].
    Wang W; Kang Y; Shu XH; Shen XD; He B
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):835-840. PubMed ID: 29151290
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
    Lipshultz SE; Miller TL; Scully RE; Lipsitz SR; Rifai N; Silverman LB; Colan SD; Neuberg DS; Dahlberg SE; Henkel JM; Asselin BL; Athale UH; Clavell LA; Laverdière C; Michon B; Schorin MA; Sallan SE
    J Clin Oncol; 2012 Apr; 30(10):1042-9. PubMed ID: 22370326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Doxorubicin, Epirubicin, and Liposomal Doxorubicin (Anthracycline) on cardiac function in patients with osteosarcoma and their influencing factors.
    Ding S; Xiong S; Wang X; Zhang C; Chen S; Sun M; Wu C; Zhang X; Wang M; Wang J; Shang X
    Clin Transl Oncol; 2024 Jun; 26(6):1459-1466. PubMed ID: 38329609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity.
    Kilickap S; Barista I; Akgul E; Aytemir K; Aksoyek S; Aksoy S; Celik I; Kes S; Tekuzman G
    Ann Oncol; 2005 May; 16(5):798-804. PubMed ID: 15774486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.
    Leger KJ; Leonard D; Nielson D; de Lemos JA; Mammen PP; Winick NJ
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28377429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
    Lipshultz SE; Scully RE; Lipsitz SR; Sallan SE; Silverman LB; Miller TL; Barry EV; Asselin BL; Athale U; Clavell LA; Larsen E; Moghrabi A; Samson Y; Michon B; Schorin MA; Cohen HJ; Neuberg DS; Orav EJ; Colan SD
    Lancet Oncol; 2010 Oct; 11(10):950-61. PubMed ID: 20850381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.
    Lipshultz SE; Rifai N; Sallan SE; Lipsitz SR; Dalton V; Sacks DB; Ottlinger ME
    Circulation; 1997 Oct; 96(8):2641-8. PubMed ID: 9355905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
    Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM
    Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment.
    Cheung YF; Li VW; Lai CT; Shin VY; Keung W; Cheuk DK; Kwong A; Li RA; Chan GC
    Pediatr Res; 2021 Apr; 89(5):1245-1252. PubMed ID: 32634817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
    Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in children.
    Kremer LC; Bastiaansen BA; Offringa M; Lam J; van Straalen JP; de Winter RJ; Voûte PA
    Eur J Cancer; 2002 Mar; 38(5):686-9. PubMed ID: 11916551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Biomarkers Predictive of Anthracycline-Induced Cardiac Dysfunction?
    Malik A; Jeyaraj PA; Calton R; Uppal B; Negi P; Shankar A; Patil J; Mahajan MK
    Asian Pac J Cancer Prev; 2016; 17(4):2301-5. PubMed ID: 27221934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines.
    Pourier MS; Kapusta L; van Gennip A; Bökkerink JP; Loonen J; Bellersen L; Mavinkurve-Groothuis AM
    Clin Chim Acta; 2015 Feb; 441():29-32. PubMed ID: 25512165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.